CDHR5 and colorectal carcinoma: To better understand the correlation between β-catenin activity and MUCDHL expression, we performed experiments in which the β-catenin signaling pathway was inhibited in CRC cell lines using a chemical inhibitor or a siRNA-based approach and showed that MUCDHL expression is upregulated by both treatments.